Lung cancer
Conditions
Interventions
Healthy People Group:None
Sponsors
The Third Medical Center of PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) Diagnosed with lung cancer through histology or cytology. 2) Two or more cycles of PD-1 immunotherapy. 3) At least one measurable lung lesion that meets the RECIST criteria or a clinical RECIST assessment result. 4) Adult patients over 18 years old, regardless of gender. 5) Patients with an ECOG score of 0-2 and an estimated survival time of at least 12 weeks. 6) Patients are included and voluntarily sign an informed consent form based on a comprehensive understanding of the experimental protocol.
Exclusion criteria
Exclusion criteria: 1) Severe comorbidities: Patients with organ dysfunction such as liver, liver, and kidneys who cannot tolerate immunotherapy; 2) Subjects have serious or uncontrolled systemic diseases and need treatment, including uncontrollable hypertension, diabetes, active bleeding diseases, mental disorders and other diseases; 3) Pregnant or lactating women 4) Uncontrolled active infections, including tuberculosis, hepatitis B, hepatitis C, etc. 5) History of immunodeficiency or organ transplantation. 6) Non primary malignant lung tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GP73; | — |
Countries
China
Contacts
Public ContactYang Xiaoli
The Third Medical Center of PLA General Hospital
Outcome results
None listed